aDepartment of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD;

bMathematica, Ann Arbor, MI; and

cDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD.

Correspondence to: Jacqueline E. Rudolph, PhD, Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, 615 N Wolfe St., Baltimore, MD 21205 (e-mail: [email protected]).

Presented at the Conference on Retroviruses and Opportunistic Infections in Seattle, WA on February 21, 2023.

The authors have no conflicts of interest to disclose.

Supported in part by NIH grants R01 CA250851, U01 AI069918, P30 CA006973, and T32 CA0093140; by American Cancer Society grant RSG-18-147-01; and by a 2018 and 2021 developmental grant from the Johns Hopkins University Center for AIDS Research, an NIH funded program (P30 AI094189), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIA, NIGMS, NIDDK, NIMHD. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jaids.com).